Sera Prognostics (SERA) Change in Intangibles (2024)
Sera Prognostics posted quarterly Change in Intangibles of $53000.0 for Q4 2024, down 82.03% on a QoQ basis from $295000.0 in Q3 2024.
Sera Prognostics (SERA) has 1 years of Change in Intangibles data on file, last reported at $53000.0 in Q4 2024.
- For the quarter ending Q4 2024, Change in Intangibles changed N/A year-over-year to $53000.0; the trailing twelve-month figure through Sep 2025 stood at $53000.0 (down 94.66% YoY), and the FY2024 full-year result was $1.0 million, changed N/A from the prior year.
- Change in Intangibles for Q4 2024 stood at $53000.0, down from $295000.0 in the prior quarter.
- Across five years, Change in Intangibles topped out at $697000.0 in Q1 2024 and bottomed at $53000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -31.61 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Sera Prognostics | 30.02 Mn | 30.02 Mn | -28,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 53,000.00 |
| Dec 31, 2024 | 53,000.00 |
| Sep 30, 2024 | 295,000.00 |
| Sep 30, 2024 | 295,000.00 |
| Mar 31, 2024 | 697,000.00 |
| Mar 31, 2024 | 697,000.00 |